Perfusion Medical, INC.
Brands
Trauma CareThis company sells these brands.
Perfusion Medical is developing PM-208, a novel intravenous therapeutic drug designed to treat hemorrhagic shock and ischemic conditions by restoring blood flow through tissue capillaries. The drug works by reversing metabolic cell and tissue swelling that occurs during shock, which reduces capillary compression and the no-reflow phenomenon. PM-208 has been developed with $19 million in Department of Defense funding and is intended to treat conditions including hemorrhagic shock, acute kidney injury, and cardiac shock.
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Perfusion Medical, INC. | Herndon | VA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.